5 completed, 1 unknown. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Brimonidine: new trials by email Literature Review of Brimonidine trials Research Report on Brimonidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Drugs, Investigational - To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients | Phase 2 | Completed | Chittagong Medical College | 80 | 2018-06-25 | 2019-12-26 |
| Dry Eye Disease Study With Brimonidine Brimonidine, Brimonidine Mono Therapy, sodium carboxymethylcellulose - Dry Eye | Phase 2 | Completed | Ocugen | 84 | 2017-09-06 | 2022-07-06 |
| Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy COLIRIOBCN070660, Placebo, Brimonidine - Diabetic Retinopathy | Phase 2 / Phase 3 | Completed | BCN Peptides | 450 | 2013-02-01 | 2016-01-12 |
| Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy Brimonidine, Placebo Lotion - Glaucoma | Phase 2 | Unknown | Nanduri, Padma, M.D., FACS | 22 | 2011-04-01 | 2011-05-02 |
| Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% 0.18% COL-118 facial gel (1.8 mg brimonidine), 0.2% brimonidine ophthalmic solution (0.1 mg brimonidine tartrate/drop), Advanced Eye Relief - Erythematous Rosacea | Phase 2 | Completed | Galderma R&D | 20 | 2008-05-01 | 2021-02-18 |
| Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab bevacizumab, anterior chamber paracentesis, acetazolamide - Macular Edema, Diabetic Retinopathy | Phase 2 | Completed | University of Sao Paulo | 2008-12-09 |
Diabetic Retinopathy (2) · Dry Eye Syndromes (1) · Glaucoma (1) · Macular Degeneration (1) · Macular Edema (1)
BCN Peptides (1) · Chittagong Medical College (1) · Galderma R&D (1) · Nanduri, Padma, M.D., FACS (1) · Ocugen (1) · University of Sao Paulo (1)
United States (3) · Bangladesh (1) · Brazil (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Portugal (1) · Spain (1) · United Kingdom (1)
James Leyden, M.D. (1) · Michael Boone, MD (1) · Padma Nanduri, MD (1)